Objectives To find a threshold body weight (BW) below 100 kg above which computed tomography pulmonary angiography (CTPA) using reduced radiation and a reduced contrast material (CM) dose provides significantly impaired quality and diagnostic confidence compared with standard-dose CTPA. Methods In this prospectively randomised study of 501 patients with suspected pulmonary embolism and BW <100 kg, 246 were allocated into the low-dose group (80 kVp, 75 ml CM) and 255 into the normal-dose group (100 kVp, 100 ml CM). Contrast-to-noise ratio (CNR) in the pulmonary trunk was calculated. Two blinded chest radiologists independently evaluated subjective image quality and diagnostic confidence. Data were compared between the normal-dose and low-dose groups in five BW subgroups. Results Vessel attenuation did not differ between the normaldose and low-dose groups within each BW subgroup (P=1.0). The CNR was higher with the normal-dose compared with the low-dose protocol (P<0.006) in all BW subgroups except for the 90-99 kg subgroup (P=0.812). Subjective image quality and diagnostic confidence did not differ between CT protocols in all subgroups (P between 0.960 and 1.0). Conclusions Subjective image quality and diagnostic confidence with 80 kVp CTPA is not different from normal-dose protocol in any BW group up to 100 kg. Key Points • 80 kVp CTPA is safe in patients weighing <100 kg • Reduced radiation and iodine dose still provide high vessel attenuation • Image quality and diagnostic confidence with low-dose CTPA is good • Diagnostic confidence does not deteriorate in obese patients weighing <100 kg
Introduction
In recent years, low tube voltage has been shown to be a powerful tool for radiation dose reduction with computed tomography (CT) angiographic applications. Image quality of such protocols has been thoroughly investigated in virtually all body regions. Several experimental and clinical studies focused on CT pulmonary angiography (CTPA) because the low X-ray absorption of aerated lungs facilitates low-dose techniques by introducing lesser noise increase compared with abdominal applications [1] [2] [3] [4] [5] . It has been established that protocols at 100 kVp tube voltage provide very similar image quality to the formerly used 120 kVp and 140 kVp techniques at a significantly lower radiation dose. As a consequence, 100 kVp tube energy is becoming more widely accepted as the standard for CTPA.
In the last decade, a tube voltage of 80 kVp has also been introduced for CTPA. One might apply low kVp at a constant iodine delivery rate solely for further reduction of radiation dose, which can reach 30-40 %, compared with 100 kVp protocols. A more interesting approach is to use the increased iodine attenuation at 80 kVp to reduce the volume of administered contrast material (CM) to the patient. The combination of lower radiation dose and a reduced CM dose at 80 kVp CT angiography is potentially valuable, especially in younger patients and in elderly subjects with impaired renal function, not only for the lungs but also for other body regions [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
Increased noise is a known potential disadvantage of the 80 kVp technique, which might impair its applicability in patients with higher body weight (BW) or body mass index (BMI). There is no consensus in the community regarding the threshold to which 80 kVp CTPA protocols can be used. Although results from a phantom study predicted that image quality is acceptable for diagnosis in a patient of up to 100 kg BW and the first clinical experiences strengthened these data [3, 7, 17] , most groups reserve 80 kVp CTPA for lean patients with low BMI or BW of less than 60-80 kg [9, 10, 18, 19] . Moreover, no prospective data have been reported on whether confidence to rule in or out PE is affected by the low-dose protocol.
Herein we report on the image quality and diagnostic confidence from a large-scale single-centre prospective randomised study that compared a standard 100 kVp CTPA protocol with a low-dose protocol at 80 kVp using both reduced radiation and a reduced CM dose. Our aim was to find a threshold BW above which the low-dose protocol provides significantly impaired quality and diagnostic confidence compared with the standard protocol in patients weighing up to 100 kg.
Materials and methods

Patients
The REDOPED (Reduced Dose in Pulmonary Embolism Detection) trial was registered with ClinicalTrials.gov (NCT01258140) and was powered to find significant differences in accuracy with normal-dose and low-dose CTPA. The study was financially supported by the Stanley Thomas Johnson Foundation. The authors had no contractual obligations towards this foundation; they are neither its employees nor its consultants, and they had full control of the data and the information in this manuscript.
The recruitment phase was open between September 2008 and December 2011 on a 7/24-h basis. Patients with indicated CTPA for suspected pulmonary embolism (PE) at the emergency department of the University Hospital Bern, Inselspital and weighing less than 100 kg, who signed the informed consent form, were randomly assigned to the normal-dose (A) or low-dose (B) group. Exclusion criteria were age less than 18 years, and contraindication to intravenous administration of iodinated contrast media. Patients weighing more than 100 kg were examined with the normal-dose protocol but were not included in the study. Morphological data, including BW and height, were recorded for all patients. Study subjects were blinded to their group assignment.
Of the 2,714 patients who underwent CTPA in the study period, only 504 were randomised. The high drop-out rate was mainly due to high overload of CT personnel or patients declining to participate in the study. Two of the 504 randomised patients withdrew their consent in retrospect and one patient was erroneously enrolled in the trial twice. Excluding these three examinations, the data of 501 patients were included in the final analysis. The normal-dose group consisted of 255 patients and the low-dose group of 246 patients (Fig. 1) .
CT protocols
The same 16-row multidetector CT system (Somatom Sensation 16; Siemens, Forchheim, Germany) was used for CTPA during the entire study period. A collimation of 16× 0.75 mm, pitch of 1.15 and tube rotation time of 0.5 s were kept unchanged in both groups. Automatic real-time tube current modulation (CareDose4D, level "average") was switched on in all patients. In group A, we used a tube voltage of 100 kVp and a quality reference tube current time product of 100 mAs. In group B, the tube voltage was decreased to 80 kVp and the quality reference tube current time product was increased to 150 mAs. These parameters were based on a phantom study and provided good image quality in a smaller patient collective [3, 7] . All patients had their arms lying above the torso during the examination.
In both patient groups, the same standard iodinated contrast medium at 300 mg I/ml (iobitridol, Xenetix 300; Guerbet, Aulnay-sous-Bois, France) was administered in an antecubital vein through a 20-or 18-gauge canula using a commercial injector (CT Expres; Swiss Medical Care, Lausanne, Switzerland). One hundred millilitres of CM was injected at a flow rate of 4 ml/s in the normal-dose group (A) and 75 ml CM was injected at 3 ml/s in the low-dose group (B), resulting in equal injection times of 25 s. The contrast bolus was followed by a saline chaser of 20 ml at the same injection rates as for the CM. A bolus tracking technique (Care Bolus; Siemens) was used for optimal opacification of the pulmonary arteries, whereas image acquisition was started 4 s after reaching 100 Hounsfield units (HU) in the main pulmonary artery.
Transverse images were contiguously reconstructed at 5 and 1 mm using standard filtered back projection and a smooth reconstruction kernel (B30f). Since maximum intensity projection (MIP) images are routinely used in our institute for aiding correct localisation of PE, overlapping MIP images were calculated from the 1-mm-thick transverse slices in the coronal and transversal planes with 10-mm thickness at 2-mm increments. All images were stored in a picture archiving and communication system (PACS).
Analysis of objective image quality
The attenuation was measured by placing circular regions of interest of 75-100 mm 2 in the centre of the main pulmonary artery on the 1-mm-thick transverse images (HU trunk ). Care was taken to avoid false registration of the vessel wall. The standard deviations of these CT numbers were used as image noise. The attenuation measured in the paraspinal muscles at the level of the pulmonary trunk served as background signal (HU backgr. ). All measurements were performed in three different slices and the averages were used for further calculation. The contrast-to-noise ratio (CNR) was computed as CNR=(HU trunk -HU backgr. )/noise.
Assessment of subjective image quality and diagnostic confidence
All examinations were randomised and independently evaluated by two expert chest radiologists (Z.S.F., A.C.) with 13 and 11 years of experience with CTPA. Although the readers were not aware of patient data and technical parameters, including CT tube voltage, the latter was sometimes obvious from the image characteristics, preventing reliable blinding in this respect. The observers rated overall image quality in the 1-mm-thick transverse images using a five-grade scale (1=bad, no diagnosis possible; 2=poor, diagnostic confidence significantly reduced; 3=moderate, but sufficient for diagnosis; 4= good; 5=excellent). In the case of a score of 3 or less, readers gave one or more reasons for deteriorated image quality: 1= increased noise; 2=CM related, including too late or too early bolus, rapid CM dilution due to low CM flow, high cardiac output or shunt; 3=artefacts (respiratory, movement or metallic); 4=pathology in the lung parenchyma, including tumour, pneumonia or atelectasis; 5=significant pleural effusion; 6= other cause with a brief description.
Readers were asked to report the presence or absence of PE, along with the level of the affected artery (main, left or right pulmonary, lobar, segmental, 1st and 2nd subsegmental) and the confidence rate of the diagnosis (1=low; 2=medium; 3=high). An embolus was claimed to be present in the case of an intraluminal filling defect in at least three consecutive 1-mm-thick transverse images without major artefacts.
Observers entered their data into a table electronically. During the image analysis, adjustments of the window level, width, and magnification were allowed. The readers used both the original transverse CT images and the MIP reconstructions to localise PE. All image analyses were performed on highdefinition LCD monitors routinely used for reporting CT images (ME355i2; Totoku Electric Co., Tokyo, Japan).
Radiation dose and figure of merit
The size-specific dose estimates (SSDE) were calculated for all patients by multiplying the volume CT dose index by a [20] . Those diameters were measured on a transverse image at the level of the pulmonary trunk and on the anterioposterior CT radiograph (topogram).
In an effort to objectively analyse changes in image quality as function of dose at various patient weights, we calculated a figure of merit (FOM) as follows: FOM=CNR 2 /SSDE [3, 21] .
Statistical analysis
Patients were classified into five subgroups on the basis of their BW (<60 kg, 60-69 kg, 70-79 kg, 80-89 kg and 90-99 kg). In order to find any significant disadvantage of the low-dose protocol in obese patients, we also grouped study subjects on the basis of their BMI (<25 kg/m 2 =underweight and normal weight; 25-30 kg/m 2 =overweight; >30 kg/m 2 = obesity). Except for gender, all patient data and image parameters were tested for normal distribution using the ShapiroWilk W test. Parameters with normal distribution were compared between the two dose groups and the various BW and BMI subgroups using analysis of variance and post hoc tests. Non-normally distributed data were compared with the Kruskal-Wallis test and gender ratio was analysed with the chi-squared test. The Kendall coefficient of concordance was computed to assess the interobserver agreement regarding overall image quality. Statistical analyses were performed with Statistica software (StatSoft, Tulsa, OK). A P value of less than 0.05 was considered statistically significant.
For the calculation of statistical power we estimated that each BW group would consist of 100 patients, 50 for each CTPA protocol. Supposing a standard deviation of 0.6, which was based on our former experience with three-and five-grade scales used for the confidence and image quality, a difference of 0.34 between the means can be proved with a power of 0.8 at a two-sided alpha-level of 0.05.
Results
Overall patient data in the normal-dose and low-dose groups
Demographic and morphological data
Unexpectedly, significantly more women were included in the low-dose group B than in the normal-dose group A (P=0.015; Table 1 ). As a consequence, mean BW and height were higher in the normal-dose group. The difference in BMI in favour of the normal-dose group just reached statistical significance (P=0.0497).
Number of PEs detected by the readers
The number of patients with PE did not differ significantly between readers (P between 0.259 and 1.0) or between groups A and B at any level of the pulmonary arterial tree (P between 0.376 and 0.952; Table 2 ). The salient inter-reader difference for the lobar arteries was resolved during a consensus reading and was due to discrepant interpretation of minimal involvement of lobar arteries at their ramifications.
Overall subjective rating of quality and cause for reduced image quality
The overall rating of subjective image quality was very similar in groups A and B (P=0.156; Table 3 ). The Kendall coefficient of concordance between the readers for the subjective quality grading was 0.630. The number of patients with decreased image quality (i.e. a grade of 3 or less) did not differ significantly between the groups (P=0.403). Readers marked a high noise level as a cause for impaired image quality more frequently in the low-dose group than in the normal-dose group (P<0.001).
Results in various BW groups
Gender ratio, age, BW, height and BMI were not significantly different between groups A and B within each BW subgroup (P between 0.069 and 1.0; Table 1) .
Objective image quality
Attenuation in the pulmonary trunk decreased with increasing BW in both groups A and B (P<0.001), but there was no difference between the normal-dose and low-dose groups within each BW subgroup (P=1.0; Fig. 2) . Except for the <60-kg (P=0.093) and the 90-to 99-kg groups (P=0.123), image noise was higher in the low-dose group in all BW classes (P<0.001). CNR was higher with the normal-dose protocol compared with the low-dose protocol (P<0.006) in all BW subgroups except for the 90-to 99-kg subgroup (P= 0.812).
Subjective image quality and diagnostic confidence
Both subjective image quality (P between 0.622 and 1.0) and diagnostic confidence (P between 0.960 and 1.0) were rated similarly with both CT protocols in all BW subgroups (Figs. 2 and 3) .
Radiation dose and FOM
SSDE was significantly lower with the low-dose CTPA protocol in all BW subgroups (P<0.001). The mean SSDE was 6.8 mGy±1.2 in the normal-dose group and 4.8 mGy±1.0 in the low-dose group (P<0.001), corresponding to a decrease of 30 %. SSDE was not significantly different between BW subgroups above 60 kg within each CT protocol (P between 0.292 and 1.0).
FOM was in general higher at lower BWs than in patients with higher BW, but there was no significant difference between the BW subgroups above 70 kg with the normal-dose protocol and above 80 kg at 80 kVp. Within each BW subgroup, 100 kVp and 80 kVp CTPA yielded very similar results (P between 0.724 and 1.0; Fig. 2 ).
Results in various BMI groups
Although only patients weighing less than 100 kg were included in this trial, 254 of 501 (50.7 %) study subjects were classified as being overweight or obese (i.e. BMI >25 kg/m 2 ; Table 4 ). Radiation exposure was significantly lower in the low-dose group than in the normal-dose group within all BMI subgroups (P<0.001) and the same was true for CNR in normal-weight and overweight patients, but not in obese patients (P=0.518). FOM, subjective image quality rating, and diagnostic confidence were not different between CTPA protocols within each BMI subgroup (P between 0.765 and 1.0). Numbers are patients with PE at the corresponding anatomical level of the pulmonary arterial tree a P values for differences between the study groups are based on averaged data derived from the two independent readers
Discussion
Former studies on low-dose CTPA were mainly retrospective in nature, we are aware of only one prospective study analysing data of 70 consecutive patients [9] . None of those series focused on image quality and diagnostic confidence in different BW groups because of the relatively low numbers of patients included.
Results of our large-scale prospective randomised trial on 501 patients provide evidence that subjective image quality and diagnostic confidence for detecting PE with normal-dose CTPA at 100 kVp and with low-dose CTPA at 80 kVp tube energy, using a reduced radiation dose by 30 % and a reduced iodine load by 25 %, do not differ significantly up to a BW of 100 kg. The weight limit of 100 kg seems to be valid for the 80 kVp CTPA protocol, as we found no significant difference in subjective image quality and diagnostic confidence compared with the normal-dose protocol in any of the BW subgroups. Nor were these parameters for both protocols significantly different in obese patients with BMI >30 kg/m 2 . The number of detected PE with both CTPA protocols was not different at all ramification levels. These data confirm findings of former experimental and retrospective studies [8, 22] .
Despite the reduced iodine flux by 25 % in the lowdose group, the mean attenuation in the pulmonary trunk did not differ from that measured in the normaldose group. As a net effect, together with the increased image noise, CNR was lower in the low-dose group. These results are well explained by the physical properties of iodine at low kVp and consistent with measurements in a chest phantom predicting increased attenuation by 25 % at constant iodine concentration when reducing tube voltage from 100 to 80 kVp [3, 23, 24] . On the contrary, an initial retrospective comparison in 90 patients showed that CTPA using 80 kVp and less CM by 25 % provided higher vessel attenuation and a similar CNR to the standard CTPA protocol at 100 kVp [7] . The current prospective randomised trial, with its markedly higher numbers of patients, provides more reliable data.
The analysis of the FOM, a parameter characterising improvement of CNR per exposure risk to the patient, showed that kVp reduction is more important in thin patients than in large patients, as FOM was higher at lower BW. As BW rises, scattering becomes an important factor and leads to higher image noise. A reduced iodine signal at a higher BW because of beam hardening also deteriorates CNR in large patients [25] . The fact that FOM did not differ between the normal-dose and low-dose groups in any weight classes indicates that the lower CNR at 80 kVp is well in balance with the reduced radiation dose compared with the 100 kVp group. The analysis of accuracy in the REDOPED study did not find any significant difference between CTPA protocols [26] .
Our trial had some limitations. Most important, only patients weighing less than 100 kg were included in the Data for subjective image quality are mean ± standard deviation, followed by the median and the quartile range in brackets. Other data are number of patients. Readers often noted more than one cause for reduced image quality in the same patient a P values for differences between the normal-dose and low-dose groups, based on averaged data over both readers Fig. 2 Box-and-whisker plots depicting objective and subjective parameters assessed with normal-dose (group A) and low-dose CTPA (group B) at various body weights. The middle point of the box represents the mean, the box values represent the standard error, and the whiskers represent the standard deviation. CNR contrast-to-noise ratio study, since results from phantom experiments predicted a significantly decreased image quality above this BW. Our subjective impression in real patients was that the 80 kVp protocol would in fact result in an image noise level that would impede diagnosis above 100 kg. However, there are no objective data to support this observation. We cannot explain the unexpected difference in the sex ratio between the study groups, as analysis of study records did not reveal systemic error or protocol violation during patient enrolment. This difference, however, did not influence the comparisons within the various weight subgroups. Although the trial included 501 individuals, the number of patients with a BW of <60 kg and 90-99 kg or with a BMI >30 kg/m 2 was relatively low, with a negative impact on the statistical power in these subgroups. Our CT unit was equipped with a relatively old detector and did not use iterative image reconstruction, since at the start of our study this tool was not yet widely available. This shows that a significant dose reduction is possible even with older CT units. From some recently published encouraging results on low kVp CTPA combined with iterative reconstruction [19] , we are convinced that the latest hardware would result in significant improvement of image quality with the 80 kVp protocol, which could facilitate its wider acceptance among radiologists or may permit the examination of patients weighing more than 100 kg. The injection time of 25 s with both CTPA protocols was rather long. More rapid scanning techniques requiring a shorter contrast bolus enable a decrease in total iodine load to the patient. We also note that the applicability of low tube voltage can be shifted towards higher BWs when using stronger real time mAs modulation. Thus, there is significant potential in our low-dose protocol for further optimisation. Since CTPA examinations have the primary goal to rule in or out PE, our quality assessment focused on the pulmonary arteries. Although analysis of image quality in the mediastinum and lung parenchyma was no subject of this investigation, our experience shows that major pathologies can be excluded in both of those localisations at 80 kVp, even in filtered back projection images.
In conclusion, 80-kVp CTPA using reduced radiation exposure and a reduced CM dose does not significantly differ from the normal-dose protocol at 100 kVp with regard to subjective image quality or diagnostic confidence in any BW class up to 100 kg. More recent technical implications will enable further dose reduction and quality improvement of the 80-kVp protocol.
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